2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
181
Lymphoid
181
Plasma cell
14
Myeloid
10
Dermatologic
4
Classical hematology
4
Sarcoma
3
Other neoplasm
2
CNS
2
Thoracic
1
Other
1
Gastrointestinal
1
Conditions
Brain Neoplasms
2313
Glioblastoma
2016
Glioma
1402
Central Nervous System Neoplasms
692
Astrocytoma
668
Neuroblastoma
647
Gliosarcoma
480
Oligodendroglioma
405
Neoplasms
405
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
256
Meningioma
229
Recurrence
224
Sarcoma
215
Melanoma
207
Neoplasm Metastasis
202
Ependymoma
200
Lung Neoplasms
199
Neurofibromatosis 1
169
Lymphoma
162
Meningeal Carcinomatosis
138
Osteosarcoma
135
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
107
Interventions
bempegaldesleukin
1
Nivolumab
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
CNS
×
Clear all
NCT04730349
2023-03-24
PIVOT IO 020
Bristol-Myers Squibb
Phase 1/2
Terminated
15 enrolled
14 charts
NCT05099068
2022-07-05
PLANET
Centre Leon Berard
Phase NA
Unknown
500 enrolled